Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/25/22
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 08/01/14
End: 04/30/20
Due: 04/30/21
Phase: N/A
Priority: Normal
Start: 09/30/14
End: 04/30/20
Due: 04/30/21
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 05/31/17
Due: 05/31/18
Phase: N/A
Priority: Normal
Start: 08/01/14
End: 04/30/18
Due: 04/30/19
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| The CATALINA Study | NCT05008081 | Wim Janssens | user2@example.com | None | 2022-10-25 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |
| BACE Trial Substudy 2 - FarmEc Substudy | NCT02205255 | Wim Janssens | user2@example.com | None | 2014-08-01 | 2020-04-30 | 2021-04-30 | - | - | 2025-07-14 |
| BACE Trial Substudy 1 - PROactive Substudy | NCT02205242 | Wim Janssens | user2@example.com | None | 2014-09-30 | 2020-04-30 | 2021-04-30 | - | - | 2025-07-14 |
| Detection of Aspergillus Fumigatus and Sensitization in COPD Patients With Bronchiectasis vs Without Bronchiectasis | NCT02332122 | Wim Janssens | user2@example.com | None | 2015-01-31 | 2017-05-31 | 2018-05-31 | - | - | 2025-07-14 |
| Azithromycin for Acute Exacerbations Requiring Hospitalization | NCT02135354 | Wim Janssens | user2@example.com | None | 2014-08-01 | 2018-04-30 | 2019-04-30 | - | - | 2025-07-14 |